Association of GABAB R1 receptor gene polymorphism with obstructive sleep apnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 642s Year: 2006
Relationship between adiponectin gene polymorphism and obstructive sleep apnea hypopnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 412s Year: 2006
The impact of serum leptin and soluble leptin receptor (sOB-R) levels on respiratory chemosensitivities in obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2006; 28: Suppl. 50, 413s Year: 2006
Angio-inhibitory activity and decreased leptin level in sera from obstructive sleep apnea syndrome (OSAS) patients Source: Eur Respir J 2001; 18: Suppl. 33, 334s Year: 2001
Association of IL-6 and TNFα and leptin receptor (LEPR) gene polymorphism with IL-6 and TNFα serum level in obstructive sleep apnea syndrome (OSAS) patients Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007
Is obstructive sleep apnoea (OSA) associated with insulin resistance (IR) in severely obese adults? Source: Annual Congress 2003 - Systematic inflammation and metabolic disorders in sleep related breathing disorders Year: 2003
Frequency of distribution of IL-1, IL-6 and TNFa gene polymorphism in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2006 - Metabolic control in obstructive sleep apnoea Year: 2006
Adiponectin is not a cardiovascular risk factor in otherwise healthy subjects with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea Year: 2009
The phenotype and genotype of adult obstructive sleep apnoea/hypopnoea syndrome Source: Eur Respir J 2009; 33: 646-655 Year: 2009
Role of LEPR A223G gene polymorphism on severity of obstructive sleep apnea Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing Year: 2013
Effect of growth hormone (GH) therapy on obstructive sleep apnea (OSA) in children with Prader Willi Syndrome (PWS) Source: Eur Respir J 2005; 26: Suppl. 49, 614s Year: 2005
The effect of growth hormone therapy, adenotonsillectomy and genotype on obstructive sleep apnea in children with Prader-Willi syndrome Source: Annual Congress 2013 –Assessing sleep disordered breathing and lung function in children Year: 2013
Is substance P (SP) involved in sleep physiology and behavioural characteristics in children with obstructive sleep apnea-hypopnea syndrome during sleep (OSAHS)? Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism Year: 2011
Metabolic disturbances in patients with obstructive sleep apnoea syndrome Source: Eur Respir Rev 2007; 16: 196-202 Year: 2007
The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 113s Year: 2004
Plasma levels of TNF in obstructive sleep apnea syndrome (OSA) before and after surgical intervention Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology Year: 2012
Serum leptin levels in obese patients with severe obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 332s Year: 2004
Trp64Arg polymorphism in children with obstructive sleep apnea (OSAS) and controls Source: Annual Congress 2013 –A paediatric palimpsest: sleep apnoea from conception to the teenage years Year: 2013
Association of obstructive sleep apnea hypopnea syndrome with cardiovascular disease: a candidate gene association study Source: Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea Year: 2020
The relationship between obstructive sleep apnea syndrome and apolipoprotein E allels Source: Annual Congress 2011 - Comorbid obstructive sleep apnoea (OSA) and OSA comorbidities Year: 2011